Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
CRISPR Therapeutics
CRSP
$4.73B
| $539K | ﹤0.01% |
13,262
-13,262
| -50% | -$704K |
|
1677
Park Hotels & Resorts
PK
$3.03B
| $538K | ﹤0.01% |
45,675
-45,681
| -50% | -$557K |
|
1678
M/I Homes
MHO
$3.74B
| $536K | ﹤0.01% |
11,618
-12,158
| -51% | -$522K |
|
|
PDCO
1679
DELISTED
Patterson Companies, Inc.
PDCO
| $536K | ﹤0.01% |
19,141
-6,943
| -27% | -$192K |
|
1680
Coty
COTY
$2.42B
| $536K | ﹤0.01% |
62,643
-62,653
| -50% | -$460K |
|
|
IBER
1681
DELISTED
Ibere Pharmaceuticals
IBER
| $534K | ﹤0.01% |
52,917
-52,917
| -50% | -$529K |
|
1682
Arrow Electronics
ARW
$11.1B
| $532K | ﹤0.01% |
5,088
+1,603
| +46% | +$165K |
|
|
AXNX
1683
DELISTED
Axonics, Inc. Common Stock
AXNX
| $532K | ﹤0.01% |
8,508
+2,000
| +31% | +$133K |
|
1684
Arcosa
ACA
$7.13B
| $531K | ﹤0.01% |
9,784
| – | – |
|
1685
Beam Therapeutics
BEAM
$2.63B
| $531K | ﹤0.01% |
13,579
-6,961
| -34% | -$312K |
|
1686
EPR Properties
EPR
$4.76B
| $531K | ﹤0.01% |
14,083
-14,083
| -50% | -$548K |
|
1687
Bankunited
BKU
$3.37B
| $531K | ﹤0.01% |
15,627
-10,227
| -40% | -$361K |
|
|
ATSG
1688
DELISTED
Air Transport Services Group
ATSG
| $531K | ﹤0.01% |
+20,429
| New | +$563K |
|
1689
Guardant Health
GH
$21.7B
| $530K | ﹤0.01% |
19,517
-15,319
| -44% | -$701K |
|
|
NAAC
1690
DELISTED
North Atlantic Acquisition Corporation Class A Ordinary Share
NAAC
| $529K | ﹤0.01% |
52,305
-52,303
| -50% | -$524K |
|
1691
Kulicke & Soffa
KLIC
$4.67B
| $529K | ﹤0.01% |
11,946
-11,946
| -50% | -$525K |
|
|
NHIC
1692
DELISTED
NewHold Investment Corp. II Class A Common Stock
NHIC
| $528K | ﹤0.01% |
52,725
-52,725
| -50% | -$527K |
|
1693
Federated Hermes
FHI
$4.55B
| $528K | ﹤0.01% |
14,548
-15,912
| -52% | -$558K |
|
|
PNTM
1694
DELISTED
Pontem Corporation
PNTM
| $527K | ﹤0.01% |
+52,133
| New | +$523K |
|
|
TPH
1695
DELISTED
Tri Pointe Homes
TPH
| $527K | ﹤0.01% |
28,328
-29,884
| -51% | -$520K |
|
1696
Otter Tail
OTTR
$3.71B
| $526K | ﹤0.01% |
8,968
+393
| +5% | +$23.5K |
|
1697
CNO Financial Group
CNO
$5.14B
| $525K | ﹤0.01% |
23,002
-23,004
| -50% | -$496K |
|
1698
Papa John's
PZZA
$984M
| $524K | ﹤0.01% |
6,363
| – | – |
|
|
KRNL
1699
DELISTED
Kernel Group Holdings, Inc. Class A Ordinary Shares
KRNL
| $523K | ﹤0.01% |
51,790
-51,790
| -50% | -$519K |
|
1700
CONMED
CNMD
$1.39B
| $521K | ﹤0.01% |
5,882
| – | – |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.